Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorStanford University
About this trial
The purpose of this study is to evaluate the efficacy of deep transcranial magnetic stimulation as a treatment for Veterans with Alcohol Use Disorder (AUD) to decrease the exceedingly high rate of relapse associated with this condition.
Eligibility criteria
Qualifiers
Age 18-75.
Current DSM-5 diagnosis of moderate to severe AUD (≥4 diagnostic symptoms).
Ability to obtain a Motor Threshold (MT) will be determined during the screening process.
Has an adequately stable condition and environment to enable attendance at scheduled clinic visits.
Disqualifiers
Transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI) contraindications: such as a cardiac pacemaker, cochlear implant, or an implanted device (deep brain stimulation, metal in the head, metal in the body, claustrophobia, pregnant or breastfeeding or other ferromagnetic device/objected in the head and body within 30 cm of the treatment coil.
General medical condition, disease or neurological disorder that interferes with the assessments or participation.
Unable to safely withdraw, at least two weeks prior to treatment, from medications that increase seizure risk.
Current substance abuse (except caffeine or nicotine) as determined by positive toxicology screen.
Trial design
Treatments tested in this trial
- Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active
- Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Sham
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Stanford University
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Source ClinicalTrials.gov